AstraZeneca
$51.829876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$51.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.25 (+0.48%) As of 2:18 PM EDT today
Why Robinhood?
You can buy or sell AstraZeneca and other stocks, options, and ETFs commission-free!
About AZN
AstraZeneca PLC American Depositary Shares, also called AstraZeneca, is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. Read More The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. The listed name for AZN is AstraZeneca PLC American Depositary Shares.
Employees
70,600
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
136.14B
Price-Earnings Ratio
63.62
Dividend Yield
2.63
Average Volume
4.03M
High Today
$52.23
Low Today
$51.63
Open Price
$52.03
Volume
2.46M
52 Week High
$64.94
52 Week Low
$36.15
Collections
AZN News
Reuters8h
Study finds AstraZeneca's COVID-19 vaccine follows genetic instructions
FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic
LONDON
Analyst Ratings
68%
of 25 ratings
Buy
68%
Hold
16%
Sell
16%
AZN Earnings
$0.00
$0.35
$0.70
$1.05
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Available Nov 5, Pre-Market
You May Also Like
More AZN News
CNBCOct 21
AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.
AstraZeneca shares turned negative Wednesday a
CNBCOct 20
AstraZeneca's U.S. coronavirus vaccine trial may resume as soon as this week, sources say
AstraZeneca's Covid-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its
ReutersOct 20
Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
CHICAGO/WASHINGTON (Reuters) - AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Fo
BenzingaOct 19
AstraZeneca Gets EU Committee Recommendation For Approval Of Heart Failure, Lung Cancer Treatments
The United Kingdom-based pharmaceutical company, AstraZeneca Plc (NASDAQ: AZN) received The Committee for Medicinal Products for Human Use (CHMP) recommendation
